Package 17772-101-10

Brand: trokendi xr

Generic: topiramate
NDC Package Sample

Package Facts

Identity

Package NDC 17772-101-10
Digits Only 1777210110
Product NDC 17772-101
Product ID 17772-101_41c182e6-f5f2-bfac-e063-6294a90a547f
Description

5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-10)

Marketing

Marketing Status
Marketed Since 2013-08-16
Brand trokendi xr
Generic topiramate
Sample Package Yes

Linked Drug Pages (1)

Trokendi XR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "41c182e6-f5f2-bfac-e063-6294a90a547f", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0317772101300", "0317772102307", "0317772104301", "0317772103304"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1436245", "1437278", "1437280", "1437283", "1437285", "1437288", "1437290"], "spl_set_id": ["2dc7957e-a3e5-46bb-aa66-f3250f872f5e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Supernus Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01)", "package_ndc": "17772-101-01", "marketing_start_date": "20130816"}, {"sample": true, "description": "7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-07)", "package_ndc": "17772-101-07", "marketing_start_date": "20200623"}, {"sample": true, "description": "5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-10)", "package_ndc": "17772-101-10", "marketing_start_date": "20130816"}, {"sample": true, "description": "7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-12)", "package_ndc": "17772-101-12", "marketing_start_date": "20130816"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-30)", "package_ndc": "17772-101-30", "marketing_start_date": "20130816"}], "brand_name": "Trokendi XR", "product_id": "17772-101_41c182e6-f5f2-bfac-e063-6294a90a547f", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "17772-101", "generic_name": "topiramate", "labeler_name": "Supernus Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trokendi XR", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "NDA201635", "marketing_category": "NDA", "marketing_start_date": "20130816", "listing_expiration_date": "20261231"}